Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Pancera

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.
Journal of Virology|July 29, 2011
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestorsMattia Bonsignori, Kwan-Ki Hwang, Xi Chen, et al.
Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Nature Medicine|December 16, 2018
Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.
Nature Medicine|March 20, 2018
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.
Science Translational Medicine|March 17, 2017
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptideS Munir Alam, Baptiste Aussedat, Yusuf Vohra, et al.
Nature Structural & Molecular Biology|December 23, 2015
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine designJason Gorman, Cinque Soto, Max M Yang, et al.
Immunity|January 15, 2013
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2Hua-Xin Liao, Mattia Bonsignori, S Munir Alam, et al.
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
Nature|November 25, 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Jason S McLellan, Marie Pancera, Chris Carrico, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.
Journal of Virology|July 29, 2011
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestorsMattia Bonsignori, Kwan-Ki Hwang, Xi Chen, et al.
Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Nature Medicine|December 16, 2018
Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.
Nature Medicine|March 20, 2018
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.
Science Translational Medicine|March 17, 2017
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptideS Munir Alam, Baptiste Aussedat, Yusuf Vohra, et al.
Nature Structural & Molecular Biology|December 23, 2015
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine designJason Gorman, Cinque Soto, Max M Yang, et al.
Immunity|January 15, 2013
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2Hua-Xin Liao, Mattia Bonsignori, S Munir Alam, et al.
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
Nature|November 25, 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Jason S McLellan, Marie Pancera, Chris Carrico, et al.
Pageof 12